Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Alexandra Lapeyre-Prost"'
Autor:
Emilie Hafliger, Alessandra Boccaccino, Alexandra Lapeyre-Prost, Audrey Perret, Claire Gallois, Maria Antista, Lorenzo Pilla, Thierry Lecomte, Mario Scartozzi, Emilie Soularue, Lisa Salvatore, Vincent Bourgeois, Massimiliano Salati, David Tougeron, Ludovic Evesque, Jean-Nicolas Vaillant, Reem El-Khoury, Sara Lonardi, Chiara Cremolini, Julien Taieb
Publikováno v:
European journal of cancer (Oxford, England : 1990). 168
Encorafenib plus cetuximab is efficient in anti-EGFR-naïve patients with BRAFWe retrospectively collected a series of patients with BRAFm mCRC treated with B + E after previous anti-EGFR treatment, in 14 centers. Progression-free survival (PFS) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::242541ca117fdb08d81cbfd366e1877b
https://pubmed.ncbi.nlm.nih.gov/35436675
https://pubmed.ncbi.nlm.nih.gov/35436675
Autor:
Jérôme Desramé, Florence Mary, Simon Pernot, Thomas Aparicio, Laetitia Dahan, Lysianne Marthey, François-Xavier Caroli-Bosc, Alexandra Lapeyre-Prost, Julien Taieb, Côme Lepage, Thierry Lecomte, Karine Le Malicot, Julie Sigrand, Solene Doat
Publikováno v:
Clinical Colorectal Cancer
Clinical Colorectal Cancer, Elsevier, 2020, 19 (4), pp.285-290. ⟨10.1016/j.clcc.2020.06.003⟩
Clinical Colorectal Cancer, 2020, 19 (4), pp.285-290. ⟨10.1016/j.clcc.2020.06.003⟩
Clinical Colorectal Cancer, Elsevier, 2020, 19 (4), pp.285-290. ⟨10.1016/j.clcc.2020.06.003⟩
Clinical Colorectal Cancer, 2020, 19 (4), pp.285-290. ⟨10.1016/j.clcc.2020.06.003⟩
Background FOLFIRI (irinotecan, 5-fluorouracil, and leucovorin) + aflibercept improves median overall survival (OS) and progression-free survival (PFS) in patients with previously treated metastatic colorectal cancer (mCRC). Our aim was to investigat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3cadda315cf4cb394e1fec82bbbc51e
https://hal.univ-angers.fr/hal-03284418
https://hal.univ-angers.fr/hal-03284418
Autor:
Alexandra Lapeyre-Prost, Julien Taieb
Publikováno v:
Côlon & Rectum. 12:161-169
Le cancer colorectal est un probleme majeur de sante publique, de par son incidence elevee et son taux de mortalite non negligeable. Chez les patients atteints de cancer du colon de stade III, operes, la chimiotherapie adjuvante a permis un gain de s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a4c10691a9b704843d7cd65d5b3ad46
https://doi.org/10.3166/cer-2018-0025
https://doi.org/10.3166/cer-2018-0025
Autor:
Elie Marcheteau, Thibault Voron, Simon Pernot, Julien Taieb, Anne-Laure Pointet, Eric Tartour, Magali Terme, Alexandra Lapeyre-Prost
Publikováno v:
Colorectal Cancer. 6:1-10
The evidence that the immune system, when rightly stimulated, can eradicate cancer cells, combined with the latest knowledge about antitumor immunity, has led to recent progress in cancer immunotherapy. While infiltration of tumors with immune cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ebb6985c49020702609c82e405fa1b6
https://doi.org/10.2217/crc-2017-0002
https://doi.org/10.2217/crc-2017-0002
Publikováno v:
British Journal of Cancer
The BRAFV600E mutation is a well-accepted poor prognostic factor in patients with metastatic colorectal cancer (mCRC), as it confers Ras-independent stimulation of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway inv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2347401959424277bcbb1e493f2b4269
https://pubmed.ncbi.nlm.nih.gov/32231291
https://pubmed.ncbi.nlm.nih.gov/32231291
Autor:
Côme Lepage, Thierry Lecomte, François-Xavier Caroli-Bosc, Alexandra Lapeyre-Prost, Lysiane Marthey, Florence Mary, Julien Taieb, Thomas Aparicio, J. Sigrand, Jérôme Desramé, S. Racine Doat, Simon Pernot, Laetitia Dahan, K. Le Malicot
Publikováno v:
Annals of Oncology. 29:viii160
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::daf653b4806c9dad0ef5157927e15e4e
https://doi.org/10.1093/annonc/mdy281.024
https://doi.org/10.1093/annonc/mdy281.024
Autor:
Astrid Lièvre, Christophe Locher, Cedric Lecaille, Géraldine Perkins, Alexandra Lapeyre-Prost, A. Pozet, David Tougeron, H. Jaulmes-Bouillot, Julien Taieb, B. Landi, M. Vallee, M. Maillet, Florence Mary, F. Bonnetain, Johann Dreanic, Jean-Louis Legoux, J.-M. Sabate
Publikováno v:
Annals of Oncology. 27:vi458
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a008e07809cb133305b59213b65d0b3
https://doi.org/10.1093/annonc/mdw384.12
https://doi.org/10.1093/annonc/mdw384.12
Publikováno v:
Internal and Emergency Medicine. 10:531-532
One of the main complications of hemodialysis catheters is upper extremity deep venous thrombosis. Although femoral, subclavian, jugular, axillary or superior vena cava thrombosis are well-known complications, hepatic vein thrombosis resulting from a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67080aeeb880e9b909298da9570a6c0f
https://doi.org/10.1007/s11739-014-1182-4
https://doi.org/10.1007/s11739-014-1182-4